Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Amortization of Deferred Charges (2018 - 2025)

TELA Bio (TELA) has 8 years of Amortization of Deferred Charges data on record, last reported at $110000.0 in Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges fell 28.1% year-over-year to $110000.0; the TTM value through Sep 2025 reached $524000.0, down 13.67%, while the annual FY2024 figure was $609000.0, 1.67% up from the prior year.
  • Amortization of Deferred Charges reached $110000.0 in Q3 2025 per TELA's latest filing, up from $109000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $181000.0 in Q2 2022 and bottomed at $109000.0 in Q2 2025.
  • Average Amortization of Deferred Charges over 5 years is $152578.9, with a median of $151000.0 recorded in 2023.
  • Peak YoY movement for Amortization of Deferred Charges: grew 16.42% in 2021, then dropped 28.1% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $176000.0 in 2021, then decreased by 14.77% to $150000.0 in 2022, then increased by 1.33% to $152000.0 in 2023, then increased by 1.32% to $154000.0 in 2024, then decreased by 28.57% to $110000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $110000.0 in Q3 2025, $109000.0 in Q2 2025, and $151000.0 in Q1 2025.